Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells.

Wawruszak, Anna; Luszczki, Jarogniew; Czerwonka, Arkadiusz; Okon, Estera; Stepulak, Andrzej

Wawruszak, Anna; Luszczki, Jarogniew; Czerwonka, Arkadiusz; Okon, Estera; Stepulak, Andrzej.

Afiliação

Wawruszak A; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Luszczki J; Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, Poland.
Czerwonka A; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Okon E; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Stepulak A; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.

Cells ; 11(7)2022 04 04.

Article em En | MEDLINE | ID: mdl-35406775

Assuntos

Antineoplásicos; Neoplasias da Mama; Furanos; Paclitaxel; Quinolinas; Antineoplásicos/farmacologia; Neoplasias da Mama/patologia; Feminino; Furanos/farmacologia; Inibidores de Histona Desacetilases/farmacologia; Humanos; Paclitaxel/farmacologia; Quinolinas/farmacologia; Sirtuína 2/antagonistas & inibidores

Palavras-chave

AGK2; SIRT2 inhibitor; breast cancer; histone deacetylase inhibitor (HDI); isobolographic analysis; paclitaxel (PAX); pharmacological interactions; sirtuin inhibitor (SIRTi)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Mama / Paclitaxel / Furanos / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Polônia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google